The Development of Health Technology Assessment in Asia: Current Status and Future Trends

Published on May 1, 2020in Value in health regional issues
· DOI :10.1016/j.vhri.2019.08.472
Gordon G. Liu19
Estimated H-index: 19
(PKU: Peking University),
Eric Q. Wu42
Estimated H-index: 42
(AG: Analysis Group)
+ 3 AuthorsHongbo Yang11
Estimated H-index: 11
(AG: Analysis Group)
Abstract Health technology assessment (HTA) has long been employed by many countries around the world, but its adoption in Asia has been slower. Only recently have a growing number of Asian countries started to implement HTA for pricing and reimbursement decisions. The objective of this article is to provide an overview of how HTA has been or is being implemented in Asia within the context of a country’s existing—and often complex—coverage, reimbursement, and pricing schemes. Three countries at different stages of HTA implementation were selected as case studies: South Korea, where there is a young yet established HTA program; Japan, where a 3-year HTA pilot program has just concluded; and China, where HTA efforts are underway but have not been formally implemented. Not only do the experiences of these 3 countries well exemplify how the organization and scope of HTA can be customized to meet a country’s unique healthcare needs, but they also provide the opportunity to outline some common key challenges that must be overcome to implement and develop HTA competencies and capabilities.
  • References (38)
  • Citations (0)
📖 Papers frequently viewed together
23 Citations
1 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Finn Børlum Kristensen (University of Southern Denmark)H-Index: 12
#2Don Husereau (U of O: University of Ottawa)H-Index: 20
Last. Allan Wailoo (University of Sheffield)H-Index: 30
view all 17 authors...
The systematic use of evidence to inform healthcare decisions, particularly health technology assessment (HTA), has gained increased recognition. HTA has become a standard policy tool for informing decision makers who must manage the entry and use of pharmaceuticals, medical devices, and other technologies (including complex interventions) within health systems, for example, through reimbursement and pricing. Despite increasing attention to HTA activities, there has been no attempt to comprehens...
5 CitationsSource
#1A FukushimaH-Index: 1
#2J DoreyH-Index: 3
Last. Mondher ToumiH-Index: 29
view all 5 authors...
1 CitationsSource
#1Xuemei Zhen (ZJU: Zhejiang University)H-Index: 3
#2Xueshan Sun (ZJU: Zhejiang University)H-Index: 2
Last. Hengjin Dong (ZJU: Zhejiang University)H-Index: 6
view all 3 authors...
Abstract Objective To review drug policies, health technology assessment (HTA), and HTA's use in drug policies in China, to further improve the quality and efficiency of drugs. Methods This study draws on multiple methods. A systematic review of the literature, review of Chinese government documents and statistical handbooks, and authors' experiences in drug policies and HTA in China were combined to achieve the objective. Results Of 571 studies identified in the initial search, 14 eligible arti...
2 CitationsSource
#1Hong Li (UC: University of Cincinnati)H-Index: 2
#2Gordon G. Liu (PKU: Peking University)H-Index: 19
Last. Shanlian HuH-Index: 6
view all 6 authors...
Abstract The China National Formulary (CNF) for reimbursable drug use, also known as the National Reimbursement Drug List (NRDL), was formally established in 2000, revised in 2004 and 2009, and covers 52% of China’s population under the government urban health insurance programs. A third major and long-awaited update to the formulary was completed in February 2017 based on intensive reviews by a group of experts in medicine, pharmacology, health economics, and health policy. Shortly after this m...
5 CitationsSource
#1Yingyao Chen (Fudan University)H-Index: 1
#2Yao He (Fudan University)H-Index: 1
Last. Lizheng Shi (Tulane University)H-Index: 2
view all 5 authors...
: Health technology assessment (HTA) is a field of scientific policy research that adopts multidisciplinary approaches to conduct systematic evaluation of health technologies and inform decision making. Although achievements have been made by HTA activities among academics, providers, and policy makers, development of the field of HTA in China is fragmented and not yet formally integrated in health policy making processes. All stakeholders need to make more efforts to strengthen HTA knowledge tr...
2 CitationsSource
#1Wei FuH-Index: 1
#2Shuli Zhao (Planning Commission (India))H-Index: 1
Last. John Goss (UC: University of Canberra)H-Index: 9
view all 5 authors...
Wei Fu and colleagues discuss the use of research to help develop evidence based health policies in China
11 CitationsSource
#1Takeru ShiroiwaH-Index: 14
#2Takashi FukudaH-Index: 16
Last. Tomoyuki Takura (UTokyo: University of Tokyo)H-Index: 7
view all 4 authors...
Economic evaluation is used for decision-making processes in healthcare technologies in many developed countries. In Japan, no health economic data have been requested for drugs, medical devices, and interventions till date. However, economic evaluation is gradually gaining importance, and a trial implementation of the cost-effectiveness evaluation of drugs and medical devices has begun. Discussions on economic evaluation began in May 2012 within a newly established sub-committee of the Chuikyo,...
12 CitationsSource
#1Lizheng Shi (Tulane University)H-Index: 22
#2Yiwei Mao (Fudan University)H-Index: 3
Last. Yingyao Chen (Fudan University)H-Index: 6
view all 7 authors...
Abstract Objectives: Economic growth and rapid development of health technology in China have created opportunities to strengthen health technology assessment (HTA) capacity. Over the time, HTA institutions have been established to conduct HTA related work. This study reviewed the current status of HTA in China and analysed the challenges of HTA development in the context of health reform under “new normal” economy. Methods: Literature review and webpage searches were used to document the develo...
4 CitationsSource
#1Surachat Ngorsuraches (South Dakota State University)H-Index: 6
#2Nathorn Chaiyakunapruk (UW: University of Wisconsin-Madison)H-Index: 25
Last. Bong-Min Yang (SNU: Seoul National University)H-Index: 15
view all 4 authors...
2 CitationsSource
#1Yuelian SunH-Index: 1
#2Hans GregersenH-Index: 44
Last. Wei YuanH-Index: 1
view all 3 authors...
: China has gone through a comprehensive health care insurance reform since 2003 and achieved universal health insurance coverage in 2011. The new health care insurance system provides China with a huge opportunity for the development of health care and medical research when its rich medical resources are fully unfolded. In this study, we review the Chinese health care system and its implication for medical research, especially within clinical epidemiology. First, we briefly review the populatio...
23 CitationsSource
Cited By0